- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 1.28B sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.38B sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.19B sh |
| Capex | Q1 2026 · Mar 31, 2026 | $67.55M |
| Capex | Q1 2026 · Mar 31, 2025 | $52.6M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.31B |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $21.5M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $3.4B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $4.93B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $2.09B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $10.81B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $10.49B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $6.68B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $6.53B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $42.89B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $40.17B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $53.7B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $50.66B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.12 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.06 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.13 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.06 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $197.58M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $156.4M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $187.68M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $156.21M |
| Net Income | Q1 2026 · Mar 31, 2026 | $166.73M |
| Net Income | Q1 2026 · Mar 31, 2025 | $71.12M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $171.12M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $135.52M |
| Revenue | Q1 2026 · Mar 31, 2026 | $129.5M |
| Revenue | Q1 2026 · Mar 31, 2025 | $140.38M |